Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Testicular Neoplasms 1Teratoma 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Hematologic Neoplasms 1Frailty 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Ifosfamide 10Carboplatin 8Paclitaxel 7Etoposide 7Filgrastim 5Dexamethasone 3Cisplatin 3Thiotepa 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Ondansetron 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Calcium Dobesilate 2Bleomycin 2Aprepitant 2tremelimumab 1thymoglobulin 1sodium thiosulfate 1poly ICLC 1pembrolizumab 1pegfilgrastim 1palifosfamide lysine 1palbociclib 1isophosphamide mustard 1fosaprepitant 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Testicular Neoplasms × Restraint, Physical × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡